Drug Development


Shares of oncology-focused biopharmaceutical company Arcus Biosciences, Inc. (RCUS) are trading 15 percent higher on Thursday. The company on Wednesday reported positive clinical activity from its three-arm randomized Phase 2 ARC-7 study. The company said that the first interim analysis of the three-arm...

Eli Lilly and Company (LLY) announced positive results from the late-stage study of its drug candidate mirikizumab in ulcerative colitis (UC).

Gilead Sciences, Inc. (GILD) and Merck (MRK) announced that they have entered into a deal to jointly develop and commercialize long-acting treatments in HIV.

fdaaprovedim sep19 22jan21 Thursday, the U.S. Food and Drug Administration approved first extended-release, injectable drug regimen for the treatment of HIV infection in adults.

Follow RTT